0001140361-18-003648.txt : 20180129
0001140361-18-003648.hdr.sgml : 20180129
20180129184221
ACCESSION NUMBER: 0001140361-18-003648
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180125
FILED AS OF DATE: 20180129
DATE AS OF CHANGE: 20180129
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kiraly Thomas E
CENTRAL INDEX KEY: 0001623986
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10670
FILM NUMBER: 18557123
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE, SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HANGER, INC.
CENTRAL INDEX KEY: 0000722723
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
IRS NUMBER: 840904275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
BUSINESS PHONE: 512-777-3800
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
FORMER COMPANY:
FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: SEQUEL CORP
DATE OF NAME CHANGE: 19890814
FORMER COMPANY:
FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC
DATE OF NAME CHANGE: 19860304
4
1
doc1.xml
FORM 4
X0306
4
2018-01-25
0
0000722723
HANGER, INC.
HGR
0001623986
Kiraly Thomas E
10910 DOMAIN DRIVE
SUITE 300
AUSTIN
TX
78758
0
1
0
0
EVP & Chief Financial Officer
Common Stock
2018-01-25
4
A
0
23844
0
A
134362
D
Common Stock
2018-01-25
4
F
0
3174
15.83
D
131188
D
Stock Options (right to buy)
12.77
2027-05-19
Common Stock
94167
94167
D
Performance Share Units
2020-05-19
Common Stock
37667
37667
D
Represents performance shares being issued to the reporting person based on the achievement of performance targets for the period beginning January 1, 2015 and ending on December 31, 2015. These performance shares if earned vest in equal tranches over a four year period, commencing on the first anniversary of the grant date. Because the Compensation Committee did not certify the attainment of the performance targets until January 25, 2018, the first two tranches were not deemed vested until that date. The remainder of the performance shares will vest in equal installments in March 2018 and March 2019.
Reflects payment of tax liability by withholding shares of stock incident to vesting of restricted stock previously issued.
Includes (i) unvested restricted shares and fully vested shares totaling 20,670 shares of stock from an initial grant of 23,844 shares of restricted stock, half of which vested on January 25, 2018 and the remainder of which will vest on March 7, 2018 and 2019; (ii) unvested restricted shares which total 25,000 shares of stock from an initial grant of 25,000 shares of restricted stock that begins to vest on March 8, 2018, (iii) unvested restricted shares and fully vested shares totaling 4,658 shares of stock from an initial grant of 5,000 shares of restricted stock that begins to vest on October 11, 2017, (iv) unvested restricted shares and fully vested shares totaling 23,328 shares of stock from an initial grant of 25,000 shares of restricted stock that begins to vest on March 7, 2017; (v) unvested restricted shares and fully vested shares totaling 14,666 shares of stock from an initial grant of 15,896 shares of restricted stock made on March 6, 2015 [continued in next footnote]
and (vi) unvested restricted shares and fully vested shares totaling 42,866 shares of stock from an initial grant of 49,660 shares of restricted stock made on October 1, 2014. Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant.
Stock options were granted under the Company's Special Equity Plan and vest 1/3 on each of May 19, 2018, 2019 and 2020.
Performance share units ("PSUs") were granted under the Company's Special Equity Plan. Each PSU represents a contingent right to receive one share of common stock if predetermined levels of absolute common stock price compounded annual growth rate are achieved over a three-year performance period ending on the third anniversary of the grant date. The number of PSUs shown in the table represents the maximum number that could be earned; the target number is one-half the maximum number.
Jessica Lochmann Allen, Attorney-in-Fact for Thomas E. Kiraly
2018-01-29